Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 1.23% | 89.07 | 1.3% | $885.86m | |
| AMGN | Amgen Inc. | 0.09% | 191.49 | 1.2% | $554.58m | |
| GILD | Gilead Sciences, Inc. | 0.72% | 65.49 | 0.9% | $453.28m | |
| ONCE | Spark Therapeutics, Inc. | -0.25% | 113.67 | 11.2% | $443.24m | |
| BIIB | Biogen Inc. | -0.58% | 323.76 | 1.3% | $352.26m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.15% | 406.99 | 2.6% | $278.79m | |
| ILMN | Illumina, Inc. | 1.61% | 310.70 | 3.5% | $273.06m | |
| BPTH | Bio-Path Holdings, Inc. | -9.32% | 25.20 | 190.1% | $257.65m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -3.05% | 181.76 | 1.9% | $239.61m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.28% | 126.47 | 15.4% | $205.98m | |
| EXAS | Exact Sciences Corporation | -0.85% | 91.15 | 25.3% | $189.71m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.43% | 132.94 | 2.0% | $178.02m | |
| A | Agilent Technologies, Inc. | 0.28% | 81.20 | 1.6% | $151.29m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.11% | 79.61 | 8.3% | $101.25m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.06% | 91.44 | 4.3% | $95.59m |
Company Profile
Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.